Per E. Karlsson

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 143 publications

Periductal myxoid stroma identifies ductal carcinoma in situ at risk of invasive recurrence.

Periductal myxoid stroma identifies ductal carcinoma in situ at risk of invasive recurrence.

Journal: Journal of the National Cancer Institute

Published: July 06, 2026

Variation in chemotherapy use across healthcare regions in Sweden and its impact on prognosis in women with HR+/HER2- early breast cancer.

Variation in chemotherapy use across healthcare regions in Sweden and its impact on prognosis in women with HR+/HER2- early breast cancer.

Journal: Breast cancer research : BCR

Published: April 30, 2026

Tolerability and adherence to adjuvant abemaciclib in hormone receptor-positive, HER2-negative, node-positive high-risk early breast cancer: a real-world study.

Tolerability and adherence to adjuvant abemaciclib in hormone receptor-positive, HER2-negative, node-positive high-risk early breast cancer: a real-world study.

Journal: Acta oncologica (Stockholm, Sweden)

Published: April 19, 2026

Investigation of a prostate cancer radiation response signature in the breast cancer SweBCG91RT randomized trial.

Investigation of a prostate cancer radiation response signature in the breast cancer SweBCG91RT randomized trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 16, 2026

Surgical Outcomes After Risk-Reducing Mastectomy Among BRCA1 and BRCA2 Carriers.

Surgical Outcomes After Risk-Reducing Mastectomy Among BRCA1 and BRCA2 Carriers.

Journal: JAMA network open

Published: April 03, 2026

Omission of axillary lymph node dissection in ultrasound-detectable axillary metastases in primary breast cancer treated by upfront surgery: prospective randomized SENOMAC-ULTRA non-inferiority trial.

Omission of axillary lymph node dissection in ultrasound-detectable axillary metastases in primary breast cancer treated by upfront surgery: prospective randomized SENOMAC-ULTRA non-inferiority trial.

Journal: BJS open

Published: January 26, 2026

The phosphoproteome of ovarian carcinoma delineates signaling signatures and potentially druggable targets across histotype stages.

The phosphoproteome of ovarian carcinoma delineates signaling signatures and potentially druggable targets across histotype stages.

Journal: NPJ precision oncology

Published: January 15, 2026

Retrospective study of comparable survival after neoadjuvant versus adjuvant chemotherapy in cT1-2N0M0 triple-negative breast cancer.

Retrospective study of comparable survival after neoadjuvant versus adjuvant chemotherapy in cT1-2N0M0 triple-negative breast cancer.

Journal: Breast cancer research and treatment

Published: November 24, 2025

Proteomic analysis of ovarian carcinoma reveals diagnostic and prognostic biomarkers with histotype- and stage-specificity.

Proteomic analysis of ovarian carcinoma reveals diagnostic and prognostic biomarkers with histotype- and stage-specificity.

Journal: Journal of ovarian research

Published: September 08, 2025

"Choosing the main character": healthcare professionals' attitudes towards counselling patients about risk disclosure to relatives in the era of mainstream cancer genetic testing.

"Choosing the main character": healthcare professionals' attitudes towards counselling patients about risk disclosure to relatives in the era of mainstream cancer genetic testing.

Journal: Familial cancer

Published: September 07, 2025

LMTK3 as a spatially regulated and stage-dependent biomarker in epithelial ovarian tumorigenesis.

LMTK3 as a spatially regulated and stage-dependent biomarker in epithelial ovarian tumorigenesis.

Journal: Molecular therapy. Oncology

Published: August 27, 2025

Immune-stromal heterogeneity in breast cancer across diverse ancestries: impact on prognosis and treatment response.

Immune-stromal heterogeneity in breast cancer across diverse ancestries: impact on prognosis and treatment response.

Journal: NPJ breast cancer

Published: July 02, 2025

Showing 1-12 of 143

Last Updated: 09/26/2026